Back to FMR LLC FMR LLC

EGRXEGRX
Showing 2 of 22 quarters

Position history for FMR LLCFMR LLC's holdings in EAGLE PHARMACEUTICALS INC

No. FMR exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 28,348 shares worth $105,738. FMR already held EGRX in its Q3 2019 13F, the earliest on record, and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$105,738

Total Shares Change

-28,348

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
28,348
-2.8%
$105,7380.0%$3.95
0

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used